Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1327 (LINC01327) is a member of the long intergenic non-coding RNA (lincRNA) class, which comprises long RNA transcripts (usually >200 nucleotides) that are transcribed from genomic regions outside of protein-coding genes; they do not typically encode proteins[1][3][7]. LincRNAs such as LINC01327 are thought to exert diverse regulatory roles in the cell, including modulating chromatin states, affecting genome architecture, stabilizing other RNAs, and influencing transcriptional regulation[3]. While the broad functional landscape of lincRNAs includes roles in fine-tuning gene expression and potential involvement in disease, there is currently no direct evidence in the provided sources that LINC01327 itself functions as a therapeutic target, molecular biomarker, or is directly modulated by approved drugs[1]. LINC01327’s aliases include TCONS_00005644, consistent with other transcriptomic annotation conventions. The role of long intergenic non-coding RNAs as a molecular class continues to be an area of active research, but as of now, LINC01327 is mainly classified as a regulatory non-coding RNA[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1327 (LINC01327).